| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.598 | 8.915 | 7.045 | 7.645 | 13.134 |
| Total Income - EUR | - | - | - | - | - | 2.598 | 8.915 | 7.045 | 7.645 | 13.134 |
| Total Expenses - EUR | - | - | - | - | - | 1.901 | 3.041 | 3.532 | 6.917 | 14.099 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 697 | 5.874 | 3.513 | 729 | -966 |
| Net Profit/Loss - EUR | - | - | - | - | - | 635 | 5.638 | 3.333 | 612 | -1.360 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alex-Respimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.691 | 6.643 | 9.881 | 8.188 | 6.638 |
| Inventories | - | - | - | - | - | 247 | 0 | 0 | 1 | 2 |
| Receivables | - | - | - | - | - | 421 | 260 | 2.376 | 5.913 | 3.406 |
| Cash | - | - | - | - | - | 1.023 | 6.383 | 7.504 | 2.275 | 3.230 |
| Shareholders Funds | - | - | - | - | - | 676 | 6.299 | 9.652 | 6.912 | 5.514 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.015 | 343 | 229 | 1.276 | 1.124 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alex-Respimed S.r.l.